BioCardia, Inc. (BCDA)
NASDAQ
BioCardia, Inc. Revenue 2010–2025
BioCardia, Inc. annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- BioCardia, Inc. revenue for the quarter ending September 30, 2025 was 0.
- BioCardia, Inc. revenue for the twelve months ending September 30, 2025 was 0, a 100.00% decrease year-over-year.
- BioCardia, Inc. annual revenue for 2025 was 0, a 100.00% decrease from 2024.
- BioCardia, Inc. annual revenue for 2024 was 58000, a 87.84% decrease from 2023.
- BioCardia, Inc. annual revenue for 2023 was 477000, a 64.72% decrease from 2022.
- BioCardia, Inc. annual revenue for 2022 was 1.4 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
BioCardia, Inc. (BCDA) — Frequently Asked Questions
BioCardia, Inc. (BCDA) is a publicly traded US company. It has a market capitalization of $9M. Explore BCDA's stock price, financial statements, earnings history, margins and key ratios below.
What is BioCardia, Inc.'s market cap?
BioCardia, Inc. (BCDA) has a market capitalization of $9M.
What is the BCDA stock price?
BCDA trades at $0.83 (+2.40% on the day).
Is BCDA profitable?
In fiscal 2025, BioCardia, Inc. reported net income of -$8M.